Efg Asset Management (North America) Corp. Krystal Biotech, Inc. Transaction History
Efg Asset Management (North America) Corp.
- $580 Million
- Q1 2025
A detailed history of Efg Asset Management (North America) Corp. transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Efg Asset Management (North America) Corp. holds 17,371 shares of KRYS stock, worth $2.43 Million. This represents 0.54% of its overall portfolio holdings.
Number of Shares
17,371
Previous 17,714
1.94%
Holding current value
$2.43 Million
Previous $2.78 Million
12.83%
% of portfolio
0.54%
Previous 0.39%
Shares
11 transactions
Others Institutions Holding KRYS
# of Institutions
328Shares Held
24.3MCall Options Held
299KPut Options Held
97.6K-
Black Rock Inc. New York, NY3.95MShares$552 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.83MShares$395 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.73MShares$382 Million7.97% of portfolio
-
State Street Corp Boston, MA1.23MShares$171 Million0.01% of portfolio
-
Capital World Investors Los Angeles, CA954KShares$133 Million0.03% of portfolio
About Krystal Biotech, Inc.
- Ticker KRYS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,664,300
- Market Cap $3.59B
- Description
- Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...